129 related articles for article (PubMed ID: 12856809)
1. The effect of low dose nylestriol-levonorgestrel replacement therapy on bone mineral density in women with postmenopausal osteoporosis.
Liao EY; Luo XH; Deng XG; Wu XP; Liao HJ; Wang PF; Mao JP; Zhu XP; Huang G; Wei QY
Endocr Res; 2003 May; 29(2):217-26. PubMed ID: 12856809
[TBL] [Abstract][Full Text] [Related]
2. Effects of different nylestriol/levonorgestrel dosages on bone metabolism in female Sprague-Dawley rats with retinoic acid-induced osteoporosis.
Liao EY; Luo XH; Wang WB; Wu XP; Zhou HD; Dai RC; Liao HJ; Yang C
Endocr Res; 2003 Feb; 29(1):23-42. PubMed ID: 12665316
[TBL] [Abstract][Full Text] [Related]
3. [Compound nylestriol tablet to prevent bone loss in osteoporotic rats].
Liu SP; Liao EY; Wu XP; Luo XH; Li HD; Chen ZN; Dai RC; Sun RY; Liu XJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):405-9. PubMed ID: 16134591
[TBL] [Abstract][Full Text] [Related]
4. Nylestriol replacement therapy in postmenopausal women. A three-year prospective study.
Cheng GJ; Liu JL; Zhang Q; Fan W; Ye HF; Wang ZQ; Pan HP
Chin Med J (Engl); 1993 Dec; 106(12):911-6. PubMed ID: 8198628
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
Warming L; Ravn P; Christiansen C
Maturitas; 2005 Feb; 50(2):78-85. PubMed ID: 15653003
[TBL] [Abstract][Full Text] [Related]
6. [Prospective study on nylestriol replacement therapy in postmenopausal women].
Cheng GJ
Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):534-8, 569. PubMed ID: 8313746
[TBL] [Abstract][Full Text] [Related]
7. [Bone metabolism in postmenopausal women and after estrogen treatment].
Song SJ
Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):79-81, 122. PubMed ID: 8344086
[TBL] [Abstract][Full Text] [Related]
8. [Study of nylestriol effect on bone histomorphometric parameters in ovariectomized rats].
Zhu M; Liu Z; Zhang X
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):86-9. PubMed ID: 11263204
[TBL] [Abstract][Full Text] [Related]
9. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
[TBL] [Abstract][Full Text] [Related]
10. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
[TBL] [Abstract][Full Text] [Related]
11. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
[TBL] [Abstract][Full Text] [Related]
12. Effects on bone mass after eight years of hormonal replacement therapy.
Eiken P; Nielsen SP; Kolthoff N
Br J Obstet Gynaecol; 1997 Jun; 104(6):702-7. PubMed ID: 9197874
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
[TBL] [Abstract][Full Text] [Related]
14. [Effect of nylestriol on bone remodeling in ovariectomized rats].
Wang BL; Jia HW; Quan JX; Qiu MC; Zhang JY
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):255-9. PubMed ID: 15256120
[TBL] [Abstract][Full Text] [Related]
15. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
Delmas PD; Bjarnason NH; Mitlak BH; Ravoux AC; Shah AS; Huster WJ; Draper M; Christiansen C
N Engl J Med; 1997 Dec; 337(23):1641-7. PubMed ID: 9385122
[TBL] [Abstract][Full Text] [Related]
16. Prospective double-blind study of CEE3 in peri- and postmenopausal women: effects on bone loss and lipoprotein lipids.
Cheng GJ; Liu JL; Zhang Q; Ye HF; Wang ZQ; Pan HP
Chin Med J (Engl); 1992 Nov; 105(11):929-33. PubMed ID: 1304463
[TBL] [Abstract][Full Text] [Related]
17. Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass.
Bolognese M; Krege JH; Utian WH; Feldman R; Broy S; Meats DL; Alam J; Lakshmanan M; Omizo M
J Clin Endocrinol Metab; 2009 Jul; 94(7):2284-9. PubMed ID: 19351734
[TBL] [Abstract][Full Text] [Related]
18. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
[TBL] [Abstract][Full Text] [Related]
19. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
